A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression
Open Access
- 26 March 2014
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 42 (3) , 611-618
Abstract
Objective: A disintegrin and metalloprotease (ADAM)10 has been implicated in the progression of various solid tumours. Little is known, however, about its role in hepatocellular carcinoma (HCC). The aim of the present study was to evaluate the protein and transcript level expression of ADAM10 in HCC patients. Methods: Samples of HCC and adjacent noncancerous liver tissue were taken during liver resection surgery. Immunostaining was used to measure ADAM10 protein expression levels and quantitative reverse– transcription polymerase chain reaction was used to measure ADAM10 mRNA expression levels. Levels of ADAM10 were compared, and a survival analysis undertaken. Results: In total, 98 HCC patient samples were studied. There were significant associations between protein levels of ADAM10 and tumour grade, amount of tumour differentiation, tumour size and the presence of metastasis. Furthermore, ADAM10 protein expression was significantly associated with shortened patient survival. Conclusions: ADAM10 is strongly expressed in a large proportion of HCC cases, which is in agreement with findings in other tumour entities. Expression of ADAM10 may serve as a useful molecular marker for HCC.Keywords
This publication has 26 references indexed in Scilit:
- ADAM-17 over-expression in gallbladder carcinoma correlates with poor prognosis of patientsMedical Oncology, 2010
- Expression of ADAM9 in CIN3 lesions and squamous cell carcinomas of the cervixGynecologic Oncology, 2009
- ADAM Proteins- Therapeutic Potential in CancerCurrent Cancer Drug Targets, 2008
- The ADAMs: signalling scissors in the tumour microenvironmentNature Reviews Cancer, 2008
- Oral contraception and the risk of hepatocellular carcinomaJournal of Hepatology, 2007
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 2006
- Hepatocellular CarcinomaJournal of Clinical Gastroenterology, 2002
- Molecular pathogenesis of human hepatocellular carcinomaNature Genetics, 2002
- The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosteroneMolecular and Cellular Endocrinology, 2000